Alphamab Oncology (HKSE:09966) Effective Interest Rate on Debt % : 4.38% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Alphamab Oncology Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Alphamab Oncology's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was HK$15.2 Mil. Alphamab Oncology's average total debt for the quarter that ended in Jun. 2023 was HK$347.9 Mil. Therefore, Alphamab Oncology's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 4.38%.

Alphamab Oncology Effective Interest Rate on Debt % Historical Data

The historical data trend for Alphamab Oncology's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphamab Oncology Effective Interest Rate on Debt % Chart

Alphamab Oncology Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

1.97

5.14

3.09

2.72

3.99

Alphamab Oncology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Effective Interest Rate on Debt %	Get a 7-Day Free Trial								2.94	3.65	1.48	4.38	3.86

Competitive Comparison of Alphamab Oncology's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Alphamab Oncology's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alphamab Oncology's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alphamab Oncology's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Alphamab Oncology's Effective Interest Rate on Debt % falls into.

Alphamab Oncology Effective Interest Rate on Debt % Calculation

Alphamab Oncology's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2022 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2021 )	+	Total Debt (A: Dec. 2022 ))	/ count )
=	-1 * -15.864	/	( (780.316	+	385.704)	/ 2 )
=	-1 * -15.864	/	583.01
=	2.72 %

where

	Total Debt (A: Dec. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	212.391	+	567.925
=	780.316

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	173.402	+	212.302
=	385.704

Alphamab Oncology's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2022 )	+	Total Debt (Q: Jun. 2023 ))	/ count )
=	-1 * -15.24	/	( (385.704	+	310.182)	/ 2 )
=	-1 * -15.24	/	347.943
=	4.38 %

where

	Total Debt (Q: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	173.402	+	212.302
=	385.704

	Total Debt (Q: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	221.325	+	88.857
=	310.182

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Alphamab Oncology (HKSE:09966) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Alphamab Oncology Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Alphamab Oncology's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphamab Oncology (HKSE:09966) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alphamab Oncology (HKSE:09966) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

3NK:Germany

Address

No. 175 Fangzhou Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215024

Website

https://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company in China with a fully integrated proprietary biologics platform in bispecifics and protein engineering. The company through its subsidiaries is engaged in discovery, development manufacturing and commercialization of biotherapeutics for cancer treatment.

Alphamab Oncology (HKSE:09966) Headlines

No Headlines